Education
About Us
Working with TipRanks
Follow Us
Longitude Capital Partners II, LLC Insider Profile
4 Followers
Longitude Capital Partners II, LLC, Ten Percent Owner at Aimmune Therapeutics, holds 4.08M shares in Rapid Micro Biosystems (Ticker: RPID), holds 3.19M shares in Aptinyx (Ticker: APTX), holds 7.51M shares in Aimmune Therapeutics (Ticker: AIMT).
Longitude Capital Partners II, LLC Aimmune Therapeutics (AIMT)Ten Percent Owner
Aimmune Therapeutics (AIMT)
Ten Percent Owner
Ranked #86,181 out of 105,518 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-33.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Longitude Capital Partners II, LLC's holdings
Insider Roles
Ten Percent Owner
Roles that Longitude Capital Partners II, LLC holds in companies
Most Profitable Insider Trade
Stock:
Aimmune Therapeutics
(AIMT)
(AIMT)
Rating:Informative Buy
Date:Mar 31, 2016 - Mar 31, 2017
Return:+60.20%
The most profitable trade made by Longitude Capital Partners II, LLC
Longitude Capital Partners II, LLC's Trading History
Aimmune Therapeutics
Mar 31, 2016
―
Informative Buy
1.09M
$259.13M
Aptinyx
Jun 26, 2018
―
Uninformative Buy
―
$306.25K
Rapid Micro Biosystems
Feb 03, 2026
Ten Percent Owner
Uninformative Sell
31.42K
$17.74M
List of latest transactions for each holding click on a transaction to see Longitude Capital Partners II, LLC's performance on stock
You May Also Like
Longitude Capital Partners II, LLC insider profile FAQ
What is the percentage of profitable transactions made by Longitude Capital Partners II, LLC?
The percentage of profitable transactions made by Longitude Capital Partners II, LLC is 33%.
What is the average return per transaction made by Longitude Capital Partners II, LLC?
The average return per transaction made by Longitude Capital Partners II, LLC is -33.90%.
What stocks does Longitude Capital Partners II, LLC hold?
Longitude Capital Partners II, LLC holds: AIMT, APTX, RPID stocks.
What was Longitude Capital Partners II, LLC’s latest transaction?
Longitude Capital Partners II, LLC latest transaction was an Uninformative Sell of $31.42K.
What was Longitude Capital Partners II, LLC's most profitable transaction?
Longitude Capital Partners II, LLC’s most profitable transaction was an Informative Buy of AIMT stock on March 31, 2016. The return on the trade was 60.20%.
What is Longitude Capital Partners II, LLC's role in Aimmune Therapeutics?
Longitude Capital Partners II, LLC's role in Aimmune Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.